Sonja A Swanson1,2, Miguel A Hernán2,3,4. 1. Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands. 2. Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, USA. 3. Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA. 4. Harvard-MIT Division of Health Sciences and Technology, Boston, MA, USA.
Abstract
Background: Instrumental variable (IV) methods are often used to identify 'local' causal effects in a subgroup of the population of interest. Such 'local' effects may not be ideal for informing clinical or policy decision making. When the instrument is non-causal, additional difficulties arise for interpreting 'local' effects. Little attention has been paid to these difficulties, even though commonly proposed instruments in epidemiology are non-causal (e.g. proxies for physician's preference; genetic variants in some Mendelian randomization studies). Methods: For IV estimates obtained from both causal and non-causal instruments under monotonicity, we present results to help investigators pose four questions about the local effect estimates obtained in their studies. (1) To what subgroup of the population does the effect pertain? Can we (2) estimate the size of or (3) describe the characteristics of this subgroup relative to the study population? (4) Can the sensitivity of the effect estimate to deviations from monotonicity be quantified? Results: We show that the common interpretations and approaches for answering these four questions are generally only appropriate in the case of causal instruments. Conclusions: Appropriate interpretation of an IV estimate under monotonicity as a 'local' effect critically depends on whether the proposed instrument is causal or non-causal. The results and formal proofs presented here can help in the transparent reporting of IV results and in enhancing the use of IV estimates in informing decision-making efforts.
Background: Instrumental variable (IV) methods are often used to identify 'local' causal effects in a subgroup of the population of interest. Such 'local' effects may not be ideal for informing clinical or policy decision making. When the instrument is non-causal, additional difficulties arise for interpreting 'local' effects. Little attention has been paid to these difficulties, even though commonly proposed instruments in epidemiology are non-causal (e.g. proxies for physician's preference; genetic variants in some Mendelian randomization studies). Methods: For IV estimates obtained from both causal and non-causal instruments under monotonicity, we present results to help investigators pose four questions about the local effect estimates obtained in their studies. (1) To what subgroup of the population does the effect pertain? Can we (2) estimate the size of or (3) describe the characteristics of this subgroup relative to the study population? (4) Can the sensitivity of the effect estimate to deviations from monotonicity be quantified? Results: We show that the common interpretations and approaches for answering these four questions are generally only appropriate in the case of causal instruments. Conclusions: Appropriate interpretation of an IV estimate under monotonicity as a 'local' effect critically depends on whether the proposed instrument is causal or non-causal. The results and formal proofs presented here can help in the transparent reporting of IV results and in enhancing the use of IV estimates in informing decision-making efforts.
Authors: Sonja A Swanson; Øyvind Holme; Magnus Løberg; Mette Kalager; Michael Bretthauer; Geir Hoff; Eline Aas; Miguel A Hernán Journal: Trials Date: 2015-11-30 Impact factor: 2.279
Authors: Monkol Lek; Konrad J Karczewski; Eric V Minikel; Kaitlin E Samocha; Eric Banks; Timothy Fennell; Anne H O'Donnell-Luria; James S Ware; Andrew J Hill; Beryl B Cummings; Taru Tukiainen; Daniel P Birnbaum; Jack A Kosmicki; Laramie E Duncan; Karol Estrada; Fengmei Zhao; James Zou; Emma Pierce-Hoffman; Joanne Berghout; David N Cooper; Nicole Deflaux; Mark DePristo; Ron Do; Jason Flannick; Menachem Fromer; Laura Gauthier; Jackie Goldstein; Namrata Gupta; Daniel Howrigan; Adam Kiezun; Mitja I Kurki; Ami Levy Moonshine; Pradeep Natarajan; Lorena Orozco; Gina M Peloso; Ryan Poplin; Manuel A Rivas; Valentin Ruano-Rubio; Samuel A Rose; Douglas M Ruderfer; Khalid Shakir; Peter D Stenson; Christine Stevens; Brett P Thomas; Grace Tiao; Maria T Tusie-Luna; Ben Weisburd; Hong-Hee Won; Dongmei Yu; David M Altshuler; Diego Ardissino; Michael Boehnke; John Danesh; Stacey Donnelly; Roberto Elosua; Jose C Florez; Stacey B Gabriel; Gad Getz; Stephen J Glatt; Christina M Hultman; Sekar Kathiresan; Markku Laakso; Steven McCarroll; Mark I McCarthy; Dermot McGovern; Ruth McPherson; Benjamin M Neale; Aarno Palotie; Shaun M Purcell; Danish Saleheen; Jeremiah M Scharf; Pamela Sklar; Patrick F Sullivan; Jaakko Tuomilehto; Ming T Tsuang; Hugh C Watkins; James G Wilson; Mark J Daly; Daniel G MacArthur Journal: Nature Date: 2016-08-18 Impact factor: 49.962
Authors: Ellen C Caniglia; Rebecca Zash; Sonja A Swanson; Kathleen E Wirth; Modiegi Diseko; Gloria Mayondi; Shahin Lockman; Mompati Mmalane; Joseph Makhema; Scott Dryden-Peterson; Kalé Z Kponee-Shovein; Oaitse John; Eleanor J Murray; Roger L Shapiro Journal: Am J Epidemiol Date: 2019-09-01 Impact factor: 4.897
Authors: Veronika W Skrivankova; Rebecca C Richmond; Benjamin A R Woolf; Neil M Davies; Sonja A Swanson; Tyler J VanderWeele; Nicholas J Timpson; Julian P T Higgins; Niki Dimou; Claudia Langenberg; Elizabeth W Loder; Robert M Golub; Matthias Egger; George Davey Smith; J Brent Richards Journal: BMJ Date: 2021-10-26
Authors: Karl Smith-Byrne; Agustin Cerani; Florence Guida; Sirui Zhou; Antonio Agudo; Krasimira Aleksandrova; Aurelio Barricarte; Miguel Rodríguez Barranco; Christoph H Bochers; Inger Torhild Gram; Jun Han; Christopher I Amos; Rayjean J Hung; Kjell Grankvist; Therese Haugdhal Nøst; Liher Imaz; María Dolores Chirlaque-López; Mikael Johansson; Rudolf Kaaks; Tilman Kühn; Richard M Martin; James D McKay; Valeria Pala; Hilary A Robbins; Torkjel M Sandanger; David Schibli; Matthias B Schulze; Ruth C Travis; Paolo Vineis; Elisabete Weiderpass; Paul Brennan; Mattias Johansson; J Brent Richards Journal: Cancer Epidemiol Biomarkers Prev Date: 2022-10-04 Impact factor: 4.090